{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:58:27Z","timestamp":1783389507748,"version":"3.54.6"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["21K16630"],"award-info":[{"award-number":["21K16630"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["20K09369"],"award-info":[{"award-number":["20K09369"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["20K09389"],"award-info":[{"award-number":["20K09389"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s11060-024-04837-6","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T11:02:13Z","timestamp":1728385333000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of preoperative seizures with reduced expression of soluble CD163, an M2 macrophage marker, in the cerebrospinal fluid in isocitrate dehydrogenase wild-type glioblastoma"],"prefix":"10.1007","volume":"171","author":[{"given":"Shunsuke","family":"Yamanishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takiko","family":"Uno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ikeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Iwahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Horii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Muragaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sasayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"4837_CR1","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1001\/jama.2015.16669","volume":"314","author":"R Stupp","year":"2015","unstructured":"Stupp R, Taillibert S, Kanner AA et al (2015) Maintenance Therapy with Tumor-Treating Fields Plus Temozolomide vs Temozolomide alone for Glioblastoma: a Randomized Clinical Trial. JAMA 314:2535\u20132543. https:\/\/doi.org\/10.1001\/jama.2015.16669","journal-title":"JAMA"},{"key":"4837_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJMoa1308345","volume":"370","author":"OL Chinot","year":"2014","unstructured":"Chinot OL, Wick W, Mason W et al (2014) Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med 370:709\u2013722. https:\/\/doi.org\/10.1056\/NEJMoa1308345","journal-title":"N Engl J Med"},{"key":"4837_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1308573","volume":"370","author":"MR Gilbert","year":"2014","unstructured":"Gilbert MR, Dignam JJ, Armstrong TS et al (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370:699\u2013708. https:\/\/doi.org\/10.1056\/NEJMoa1308573","journal-title":"N Engl J Med"},{"key":"4837_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/s0959-8049(97)00374-2","volume":"34","author":"K Lote","year":"1998","unstructured":"Lote K, Stenwig AE, Skullerud K, Hirschberg H (1998) Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer 34:98\u2013102. https:\/\/doi.org\/10.1016\/s0959-8049(97)00374-2","journal-title":"Eur J Cancer"},{"key":"4837_CR5","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00415-009-5156-9","volume":"256","author":"MSM van Breemen","year":"2009","unstructured":"van Breemen MSM, Rijsman RM, Taphoorn MJB et al (2009) Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol 256:1519\u20131526. https:\/\/doi.org\/10.1007\/s00415-009-5156-9","journal-title":"J Neurol"},{"key":"4837_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/epi.12437","volume":"9","author":"M Kerkhof","year":"2013","unstructured":"Kerkhof M, Vecht CJ (2013) Seizure characteristics and prognostic factors of gliomas. Epilepsia 54 Suppl 9:12\u201317. https:\/\/doi.org\/10.1111\/epi.12437","journal-title":"Epilepsia 54 Suppl"},{"key":"4837_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.seizure.2015.12.013","volume":"35","author":"P Yang","year":"2016","unstructured":"Yang P, Liang T, Zhang C et al (2016) Clinicopathological factors predictive of postoperative seizures in patients with gliomas. Seizure 35:93\u201399. https:\/\/doi.org\/10.1016\/j.seizure.2015.12.013","journal-title":"Seizure"},{"key":"4837_CR8","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3171\/2011.7.JNS11536","volume":"115","author":"DJ Englot","year":"2011","unstructured":"Englot DJ, Han SJ, Lawton MT, Chang EF (2011) Predictors of seizure freedom in the surgical treatment of supratentorial cavernous malformations. J Neurosurg 115:1169\u20131174. https:\/\/doi.org\/10.3171\/2011.7.JNS11536","journal-title":"J Neurosurg"},{"key":"4837_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1468-1331.2011.03509.x","volume":"19","author":"G You","year":"2012","unstructured":"You G, Huang L, Yang P et al (2012) Clinical and molecular genetic factors affecting postoperative seizure control of 183 Chinese adult patients with low-grade gliomas. Eur J Neurol 19:298\u2013306. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03509.x","journal-title":"Eur J Neurol"},{"key":"4837_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","volume":"6","author":"MSM van Breemen","year":"2007","unstructured":"van Breemen MSM, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6:421\u2013430. https:\/\/doi.org\/10.1016\/S1474-4422(07)70103-5","journal-title":"Lancet Neurol"},{"key":"4837_CR11","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.2174\/1871530320999201116200940","volume":"21","author":"AN Kamali","year":"2021","unstructured":"Kamali AN, Zian Z, Bautista JM et al (2021) The potential role of pro-inflammatory and anti-inflammatory cytokines in Epilepsy Pathogenesis. Endocr Metab Immune Disord Drug Targets 21:1760\u20131774. https:\/\/doi.org\/10.2174\/1871530320999201116200940","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"4837_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/npp.2016.199","volume":"42","author":"E Haroon","year":"2017","unstructured":"Haroon E, Miller AH, Sanacora G (2017) Inflammation, glutamate, and Glia: a Trio of trouble in Mood disorders. Neuropsychopharmacology 42:193\u2013215. https:\/\/doi.org\/10.1038\/npp.2016.199","journal-title":"Neuropsychopharmacology"},{"key":"4837_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jocn.2019.07.020","volume":"68","author":"T Hori","year":"2019","unstructured":"Hori T, Sasayama T, Tanaka K et al (2019) Tumor-associated macrophage related interleukin-6 in cerebrospinal fluid as a prognostic marker for glioblastoma. J Clin Neurosci 68:281\u2013289. https:\/\/doi.org\/10.1016\/j.jocn.2019.07.020","journal-title":"J Clin Neurosci"},{"key":"4837_CR14","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","volume":"181","author":"F Klemm","year":"2020","unstructured":"Klemm F, Maas RR, Bowman RL et al (2020) Interrogation of the Microenvironmental Landscape in Brain Tumors reveals Disease-specific alterations of Immune cells. Cell 181:1643\u20131660e17. https:\/\/doi.org\/10.1016\/j.cell.2020.05.007","journal-title":"Cell"},{"key":"4837_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s12094-015-1373-0","volume":"18","author":"W Hu","year":"2016","unstructured":"Hu W, Li X, Zhang C et al (2016) Tumor-associated macrophages in cancers. Clin Transl Oncol 18:251\u2013258. https:\/\/doi.org\/10.1007\/s12094-015-1373-0","journal-title":"Clin Transl Oncol"},{"key":"4837_CR16","first-page":"105","volume":"16","author":"N Kawanishi","year":"2010","unstructured":"Kawanishi N, Yano H, Yokogawa Y, Suzuki K (2010) Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc Immunol Rev 16:105\u2013118","journal-title":"Exerc Immunol Rev"},{"key":"4837_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-1-4939-7837-3_12","volume":"1784","author":"X Huang","year":"2018","unstructured":"Huang X, Li Y, Fu M, Xin H-B (2018) Polarizing macrophages in Vitro. Methods Mol Biol 1784:119\u2013126. https:\/\/doi.org\/10.1007\/978-1-4939-7837-3_12","journal-title":"Methods Mol Biol"},{"key":"4837_CR18","doi-asserted-by":"publisher","first-page":"107603","DOI":"10.1016\/j.intimp.2021.107603","volume":"96","author":"N Du","year":"2021","unstructured":"Du N, Wu K, Zhang J et al (2021) Inonotsuoxide B regulates M1 to M2 macrophage polarization through sirtuin-1\/endoplasmic reticulum stress axis. Int Immunopharmacol 96:107603. https:\/\/doi.org\/10.1016\/j.intimp.2021.107603","journal-title":"Int Immunopharmacol"},{"key":"4837_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/bpa.12318","volume":"26","author":"T Sasayama","year":"2016","unstructured":"Sasayama T, Tanaka K, Mizowaki T et al (2016) Tumor-Associated macrophages Associate with Cerebrospinal Fluid Interleukin-10 and survival in primary central nervous system lymphoma (PCNSL). Brain Pathol 26:479\u2013487. https:\/\/doi.org\/10.1111\/bpa.12318","journal-title":"Brain Pathol"},{"key":"4837_CR20","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1186\/s12885-021-08825-1","volume":"21","author":"CL Kemmerer","year":"2021","unstructured":"Kemmerer CL, Schittenhelm J, Dubois E et al (2021) Cerebrospinal fluid cytokine levels are associated with macrophage infiltration into tumor tissues of glioma patients. BMC Cancer 21:1108. https:\/\/doi.org\/10.1186\/s12885-021-08825-1","journal-title":"BMC Cancer"},{"key":"4837_CR21","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1016\/j.wneu.2022.01.056","volume":"160","author":"M Hashiguchi","year":"2022","unstructured":"Hashiguchi M, Tanaka K, Nagashima H et al (2022) Glutamic acid and total creatine as predictive markers for Epilepsy in Glioblastoma by using magnetic resonance spectroscopy before surgery. World Neurosurg 160:e501\u2013e510. https:\/\/doi.org\/10.1016\/j.wneu.2022.01.056","journal-title":"World Neurosurg"},{"key":"4837_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3171\/2022.12.JNS221954","volume":"139","author":"H Iwahashi","year":"2023","unstructured":"Iwahashi H, Nagashima H, Tanaka K et al (2023) 2-Hydroxyglutarate magnetic resonance spectroscopy in adult brainstem glioma. J Neurosurg 139:355\u2013362. https:\/\/doi.org\/10.3171\/2022.12.JNS221954","journal-title":"J Neurosurg"},{"key":"4837_CR23","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1093\/neuonc\/now090","volume":"18","author":"H Nagashima","year":"2016","unstructured":"Nagashima H, Tanaka K, Sasayama T et al (2016) Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma. Neuro Oncol 18:1559\u20131568. https:\/\/doi.org\/10.1093\/neuonc\/now090","journal-title":"Neuro Oncol"},{"key":"4837_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10334-013-0393-4","volume":"27","author":"D Graveron-Demilly","year":"2014","unstructured":"Graveron-Demilly D (2014) Quantification in magnetic resonance spectroscopy based on semi-parametric approaches. MAGMA 27:113\u2013130. https:\/\/doi.org\/10.1007\/s10334-013-0393-4","journal-title":"MAGMA"},{"key":"4837_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1212\/WNL.0b013e318266fa89","volume":"79","author":"TI Yuen","year":"2012","unstructured":"Yuen TI, Morokoff AP, Bjorksten A et al (2012) Glutamate is associated with a higher risk of seizures in patients with gliomas. Neurology 79:883\u2013889. https:\/\/doi.org\/10.1212\/WNL.0b013e318266fa89","journal-title":"Neurology"},{"key":"4837_CR26","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1111\/epi.16731","volume":"61","author":"OM Gonen","year":"2020","unstructured":"Gonen OM, Moffat BA, Desmond PM et al (2020) Seven-tesla quantitative magnetic resonance spectroscopy of glutamate, \u03b3-aminobutyric acid, and glutathione in the posterior cingulate cortex\/precuneus in patients with epilepsy. Epilepsia 61:2785\u20132794. https:\/\/doi.org\/10.1111\/epi.16731","journal-title":"Epilepsia"},{"key":"4837_CR27","doi-asserted-by":"publisher","first-page":"244ra89","DOI":"10.1126\/scitranslmed.3008065","volume":"6","author":"J Pallud","year":"2014","unstructured":"Pallud J, Le Van Quyen M, Bielle F et al (2014) Cortical GABAergic excitation contributes to epileptic activities around human glioma. Sci Transl Med 6:244ra89. https:\/\/doi.org\/10.1126\/scitranslmed.3008065","journal-title":"Sci Transl Med"},{"key":"4837_CR28","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.febslet.2008.04.053","volume":"582","author":"N Vanhoutte","year":"2008","unstructured":"Vanhoutte N, Hermans E (2008) Glutamate-induced glioma cell proliferation is prevented by functional expression of the glutamate transporter GLT-1. FEBS Lett 582:1847\u20131852. https:\/\/doi.org\/10.1016\/j.febslet.2008.04.053","journal-title":"FEBS Lett"},{"key":"4837_CR29","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1158\/0008-5472.CAN-04-3626","volume":"65","author":"JF de Groot","year":"2005","unstructured":"de Groot JF, Liu TJ, Fuller G, Yung WKA (2005) The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo. Cancer Res 65:1934\u20131940. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3626","journal-title":"Cancer Res"},{"key":"4837_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1471-4159.2008.05301.x","volume":"105","author":"H Sontheimer","year":"2008","unstructured":"Sontheimer H (2008) A role for glutamate in growth and invasion of primary brain tumors. J Neurochem 105:287\u2013295. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05301.x","journal-title":"J Neurochem"},{"key":"4837_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11060-018-2785-9","volume":"138","author":"MF S\u00f8rensen","year":"2018","unstructured":"S\u00f8rensen MF, Heimisd\u00f3ttir SB, S\u00f8rensen MD et al (2018) High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma. J Neurooncol 138:49\u201353. https:\/\/doi.org\/10.1007\/s11060-018-2785-9","journal-title":"J Neurooncol"},{"key":"4837_CR32","doi-asserted-by":"publisher","unstructured":"Kwon DH, Lee H, Park C et al (2019) Glutathione Induced Immune-Stimulatory activity by promoting M1-Like macrophages polarization via potential ROS scavenging capacity. Antioxid (Basel) 8. https:\/\/doi.org\/10.3390\/antiox8090413","DOI":"10.3390\/antiox8090413"},{"key":"4837_CR33","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1002\/cam4.3048","volume":"9","author":"M Maeyama","year":"2020","unstructured":"Maeyama M, Sasayama T, Tanaka K et al (2020) Multi-marker algorithms based on CXCL13, IL-10, sIL-2 receptor, and \u03b22-microglobulin in cerebrospinal fluid to diagnose CNS lymphoma. Cancer Med 9:4114\u20134125. https:\/\/doi.org\/10.1002\/cam4.3048","journal-title":"Cancer Med"},{"key":"4837_CR34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/neuonc\/nor203","volume":"14","author":"T Sasayama","year":"2012","unstructured":"Sasayama T, Nakamizo S, Nishihara M et al (2012) Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL). Neuro Oncol 14:368\u2013380. https:\/\/doi.org\/10.1093\/neuonc\/nor203","journal-title":"Neuro Oncol"},{"key":"4837_CR35","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1182\/blood-2013-01-476333","volume":"121","author":"JL Rubenstein","year":"2013","unstructured":"Rubenstein JL, Wong VS, Kadoch C et al (2013) CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma. Blood 121:4740\u20134748. https:\/\/doi.org\/10.1182\/blood-2013-01-476333","journal-title":"Blood"},{"key":"4837_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.seizure.2021.06.030","volume":"91","author":"L Langenbruch","year":"2021","unstructured":"Langenbruch L, Wiendl H, Gro\u00df C, Kovac S (2021) Diagnostic utility of cerebrospinal fluid (CSF) findings in seizures and epilepsy with and without autoimmune-associated disease. Seizure 91:233\u2013243. https:\/\/doi.org\/10.1016\/j.seizure.2021.06.030","journal-title":"Seizure"},{"key":"4837_CR37","doi-asserted-by":"publisher","first-page":"708186","DOI":"10.3389\/fimmu.2021.708186","volume":"12","author":"EA Ross","year":"2021","unstructured":"Ross EA, Devitt A, Johnson JR (2021) Macrophages: the good, the bad, and the gluttony. Front Immunol 12:708186. https:\/\/doi.org\/10.3389\/fimmu.2021.708186","journal-title":"Front Immunol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04837-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04837-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04837-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T17:03:21Z","timestamp":1735578201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04837-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4837"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04837-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"assertion":[{"value":"29 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the ethics review board of Kobe University (B230181).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"We declare that this work has not been published previously or submitted elsewhere for review.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Previous presentations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}